Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| APPLIED MATERIALS INC /DEAMAT · Entity 2812 | Director | May 21, 2026 | May 22, 2026 |
| SYNOPSYS INCSNPS · Entity 210 | Director · EXECUTIVE CHAIR | August 31, 2026 | September 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
APPLIED MATERIALS INC /DE
Report date May 21, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 93,928 |
Reported balance
After 2026-05-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-21 · Gift · Disposed 17,855 · Balance 93,928 F1: Number of shares includes 741 restricted stock units previously reported that in the future will be converted on a one-for-one basis into shares of Applied Materials, Inc. common stock upon vesting, which vesting is scheduled to occur in March 2027 (subject to continued service as a director through the vesting date). |
Filing footnotes · ownership attribution and instrument terms
F1: Number of shares includes 741 restricted stock units previously reported that in the future will be converted on a one-for-one basis into shares of Applied Materials, Inc. common stock upon vesting, which vesting is scheduled to occur in March 2027 (subject to continued service as a director through the vesting date).
SYNOPSYS INC
Report date August 31, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 120,443 |
Ending reported balance
After 2026-09-01 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-08-31 · Exercise / conversion · Acquired 25,000 · Balance 145,421 Row 2 · 2026-08-31 · Sale · Disposed 25,000 · Balance 120,421 F1: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $435.88 to $445.70. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Row 3 · 2026-08-31 · Other · Acquired 22 · Balance 120,443 F2: Acquisition of stock under Synopsys, Inc Employee Stock Purchase Plan Row 4 · 2026-09-01 · Exercise / conversion · Acquired 24,641 · Balance 145,084 Row 5 · 2026-09-01 · Sale · Disposed 24,641 · Balance 120,443 F3: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $413.99 to $430.26. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $135.88 · Expires 2026-12-12 | Direct | 24,641 |
Reported balance
After 2026-08-31 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-08-31 · Exercise / conversion · Disposed 25,000 · Balance 24,641 F4: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted October 14, 2025. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $135.88 · Expires 2026-12-12 | Direct | 0 |
Reported balance
After 2026-09-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-09-01 · Exercise / conversion · Disposed 24,641 · Balance 0 F4: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted October 14, 2025. |
| Common StockSEC Table I · non-derivative | Indirectby Family Trust | 308,791 |
Reported balance
Holding disclosure · report date 2026-08-31 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 308,791 |
| Common StockSEC Table I · non-derivative | Indirectby Partnership | 14,500 |
Reported balance
Holding disclosure · report date 2026-08-31 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 14,500 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $435.88 to $445.70. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2: Acquisition of stock under Synopsys, Inc Employee Stock Purchase Plan
F3: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $413.99 to $430.26. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
F4: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted October 14, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 06, 2024 Filed Dec 10, 2024 16:56 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 1,868 | $0.00 | $0.00 |
DisclosureSEC source: 0001517737-24-000116 · edgardoc.xml · nonDerivative · entry 5 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each stock unit converts into one share of Synopsys common stock. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 16:56 UTC | SYNOPSYS INC SNPS · Entity 210 | Tax withholdingCommon Stock | 5,657 | $517.28 | $2,926,252.96 |
DisclosureSEC source: 0001517737-24-000116 · edgardoc.xml · nonDerivative · entry 4 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,639 F2 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the reporting person in connection with the vesting of an installment of the restricted stock unit award. The Compensation Committee approved the disposition of shares by the reporting person and the amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 16:56 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 11,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001517737-24-000116 · edgardoc.xml · nonDerivative · entry 3 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,296 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each stock unit converts into one share of Synopsys common stock. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 16:56 UTC | SYNOPSYS INC SNPS · Entity 210 | Tax withholdingCommon Stock | 1,853 | $517.28 | $958,519.84 |
DisclosureSEC source: 0001517737-24-000116 · edgardoc.xml · nonDerivative · entry 2 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,888 F2 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the reporting person in connection with the vesting of an installment of the restricted stock unit award. The Compensation Committee approved the disposition of shares by the reporting person and the amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 16:56 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 3,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001517737-24-000116 · edgardoc.xml · nonDerivative · entry 1 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each stock unit converts into one share of Synopsys common stock. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 15:14 UTC | SYNOPSYS INC SNPS · Entity 210 | OtherCommon Stock | 22 | $441.64 | $9,716.15 |
DisclosureSEC source: 0001517737-24-000098 · edgardoc.xml · nonDerivative · entry 1 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,005 F1 · kind: Acquisition of stock under Synopsys, Inc Employee Stock Purchase Plan Read SEC document |
| July 16, 2024 Filed Jul 17, 2024 18:58 UTC | SYNOPSYS INC SNPS · Entity 210 | GiftCommon Stock | 186,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001517737-24-000089 · edgardoc.xml · nonDerivative · entry 3 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Indirect · by Separate Prop Tr Disclosed balance after: 0 F2 · ownership.nature: The reporting person transferred shares from a separate property trust to a family trust. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 18:58 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 493 | $0.00 Strike: $89.76 | $0.00 |
DisclosureSEC source: 0001517737-24-000089 · edgardoc.xml · derivative · entry 6 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,705 Underlying: Common Stock · 493 shares Expires 2025-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Exercise and sale of option shares effected pursuant to a Rule 10b5-1 trading plan that was adopted on March 25, 2024. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 18:58 UTC | SYNOPSYS INC SNPS · Entity 210 | SaleCommon Stock | 493 | $620.60 | $305,953.58 |
DisclosureSEC source: 0001517737-24-000089 · edgardoc.xml · nonDerivative · entry 2 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,983 F1 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $620.390 to $620.935. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 18:58 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 493 | $89.76 | $44,251.68 |
DisclosureSEC source: 0001517737-24-000089 · edgardoc.xml · nonDerivative · entry 1 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2024 Filed Jul 12, 2024 15:11 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,588 | $0.00 Strike: $89.76 | $0.00 |
DisclosureSEC source: 0001517737-24-000087 · edgardoc.xml · derivative · entry 9 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,198 Underlying: Common Stock · 4,588 shares Expires 2025-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted March 25, 2024. Read SEC document |
| July 11, 2024 Filed Jul 12, 2024 15:11 UTC | SYNOPSYS INC SNPS · Entity 210 | SaleCommon Stock | 4,588 | $621.68 | $2,852,272.89 |
DisclosureSEC source: 0001517737-24-000087 · edgardoc.xml · nonDerivative · entry 4 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,983 F2 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $620.00 to $624.31. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| July 11, 2024 Filed Jul 12, 2024 15:11 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 4,588 | $89.76 | $411,818.88 |
DisclosureSEC source: 0001517737-24-000087 · edgardoc.xml · nonDerivative · entry 3 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2024 Filed Jul 12, 2024 15:11 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 8,648 | $0.00 Strike: $89.76 | $0.00 |
DisclosureSEC source: 0001517737-24-000087 · edgardoc.xml · derivative · entry 8 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,786 Underlying: Common Stock · 8,648 shares Expires 2025-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted March 25, 2024. Read SEC document |
| July 10, 2024 Filed Jul 12, 2024 15:11 UTC | SYNOPSYS INC SNPS · Entity 210 | SaleCommon Stock | 8,648 | $620.29 | $5,364,265.33 |
DisclosureSEC source: 0001517737-24-000087 · edgardoc.xml · nonDerivative · entry 2 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,983 F1 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $620.00 to $620.97. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| July 10, 2024 Filed Jul 12, 2024 15:11 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 8,648 | $89.76 | $776,244.48 |
DisclosureSEC source: 0001517737-24-000087 · edgardoc.xml · nonDerivative · entry 1 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,631 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2024 Filed Jul 9, 2024 15:15 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,448 | $0.00 Strike: $89.76 | $0.00 |
DisclosureSEC source: 0001517737-24-000085 · edgardoc.xml · derivative · entry 9 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,434 Underlying: Common Stock · 5,448 shares Expires 2025-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted March 25, 2024. Read SEC document |
| July 08, 2024 Filed Jul 9, 2024 15:15 UTC | SYNOPSYS INC SNPS · Entity 210 | SaleCommon Stock | 5,448 | $620.95 | $3,382,929.06 |
DisclosureSEC source: 0001517737-24-000085 · edgardoc.xml · nonDerivative · entry 4 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,983 F2 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $620.00 to $621.65. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| July 08, 2024 Filed Jul 9, 2024 15:15 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 5,448 | $89.76 | $489,012.48 |
DisclosureSEC source: 0001517737-24-000085 · edgardoc.xml · nonDerivative · entry 3 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 15:15 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 27,753 | $0.00 Strike: $89.76 | $0.00 |
DisclosureSEC source: 0001517737-24-000085 · edgardoc.xml · derivative · entry 8 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,882 Underlying: Common Stock · 27,753 shares Expires 2025-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted March 25, 2024. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 15:15 UTC | SYNOPSYS INC SNPS · Entity 210 | SaleCommon Stock | 27,753 | $618.58 | $17,167,470.17 |
DisclosureSEC source: 0001517737-24-000085 · edgardoc.xml · nonDerivative · entry 2 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,983 F1 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $610.525 to $622.380. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 15:15 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 27,753 | $89.76 | $2,491,109.28 |
DisclosureSEC source: 0001517737-24-000085 · edgardoc.xml · nonDerivative · entry 1 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 134,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 03, 2024 Filed Jul 5, 2024 14:09 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,789 | $0.00 Strike: $89.76 | $0.00 |
DisclosureSEC source: 0001517737-24-000083 · edgardoc.xml · derivative · entry 9 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,635 Underlying: Common Stock · 2,789 shares Expires 2025-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted March 25, 2024. Read SEC document |
| July 03, 2024 Filed Jul 5, 2024 14:09 UTC | SYNOPSYS INC SNPS · Entity 210 | SaleCommon Stock | 2,789 | $610.94 | $1,703,912.22 |
DisclosureSEC source: 0001517737-24-000083 · edgardoc.xml · nonDerivative · entry 4 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,983 F2 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $610.000 to $612.125. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| July 03, 2024 Filed Jul 5, 2024 14:09 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 2,789 | $89.76 | $250,340.64 |
DisclosureSEC source: 0001517737-24-000083 · edgardoc.xml · nonDerivative · entry 3 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2024 Filed Jul 5, 2024 14:09 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,340 | $0.00 Strike: $89.76 | $0.00 |
DisclosureSEC source: 0001517737-24-000083 · edgardoc.xml · derivative · entry 8 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,424 Underlying: Common Stock · 4,340 shares Expires 2025-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted March 25, 2024. Read SEC document |
| July 02, 2024 Filed Jul 5, 2024 14:09 UTC | SYNOPSYS INC SNPS · Entity 210 | SaleCommon Stock | 4,340 | $610.25 | $2,648,497.59 |
DisclosureSEC source: 0001517737-24-000083 · edgardoc.xml · nonDerivative · entry 2 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,983 F1 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $610.00 to $610.60. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| July 02, 2024 Filed Jul 5, 2024 14:09 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 4,340 | $89.76 | $389,558.40 |
DisclosureSEC source: 0001517737-24-000083 · edgardoc.xml · nonDerivative · entry 1 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 15:20 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,893 | $0.00 Strike: $89.76 | $0.00 |
DisclosureSEC source: 0001517737-24-000081 · edgardoc.xml · derivative · entry 9 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,764 Underlying: Common Stock · 5,893 shares Expires 2025-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted March 25, 2024. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 15:20 UTC | SYNOPSYS INC SNPS · Entity 210 | SaleCommon Stock | 5,893 | $602.00 | $3,547,563.61 |
DisclosureSEC source: 0001517737-24-000081 · edgardoc.xml · nonDerivative · entry 4 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,983 F2 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $600.08 to $604.02. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 15:20 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 5,893 | $89.76 | $528,955.68 |
DisclosureSEC source: 0001517737-24-000081 · edgardoc.xml · nonDerivative · entry 3 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 15:20 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,185 | $0.00 Strike: $89.76 | $0.00 |
DisclosureSEC source: 0001517737-24-000081 · edgardoc.xml · derivative · entry 8 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,657 Underlying: Common Stock · 11,185 shares Expires 2025-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted March 25, 2024. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 15:20 UTC | SYNOPSYS INC SNPS · Entity 210 | SaleCommon Stock | 11,185 | $603.94 | $6,755,056.60 |
DisclosureSEC source: 0001517737-24-000081 · edgardoc.xml · nonDerivative · entry 2 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,983 F1 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $600.00 to $608.00. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 15:20 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 11,185 | $89.76 | $1,003,965.60 |
DisclosureSEC source: 0001517737-24-000081 · edgardoc.xml · nonDerivative · entry 1 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 27, 2024 Filed Jun 28, 2024 16:08 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 8,158 | $0.00 Strike: $89.76 | $0.00 |
DisclosureSEC source: 0001517737-24-000079 · edgardoc.xml · derivative · entry 9 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,842 Underlying: Common Stock · 8,158 shares Expires 2025-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted March 25, 2024. Read SEC document |
| June 27, 2024 Filed Jun 28, 2024 16:08 UTC | SYNOPSYS INC SNPS · Entity 210 | SaleCommon Stock | 8,158 | $602.59 | $4,915,912.90 |
DisclosureSEC source: 0001517737-24-000079 · edgardoc.xml · nonDerivative · entry 4 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,983 F2 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $600.31 to $605.78. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| June 27, 2024 Filed Jun 28, 2024 16:08 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 8,158 | $89.76 | $732,262.08 |
DisclosureSEC source: 0001517737-24-000079 · edgardoc.xml · nonDerivative · entry 3 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2024 Filed Jun 28, 2024 16:08 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,899 | $0.00 Strike: $89.76 | $0.00 |
DisclosureSEC source: 0001517737-24-000079 · edgardoc.xml · derivative · entry 8 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 2,899 shares Expires 2025-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted March 25, 2024. Read SEC document |
| June 26, 2024 Filed Jun 28, 2024 16:08 UTC | SYNOPSYS INC SNPS · Entity 210 | SaleCommon Stock | 2,899 | $600.57 | $1,741,062.00 |
DisclosureSEC source: 0001517737-24-000079 · edgardoc.xml · nonDerivative · entry 2 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,983 F1 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $600.000 to $601.265. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| June 26, 2024 Filed Jun 28, 2024 16:08 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 2,899 | $89.76 | $260,214.24 |
DisclosureSEC source: 0001517737-24-000079 · edgardoc.xml · nonDerivative · entry 1 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 25, 2024 Filed Jun 26, 2024 14:40 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,212 | $0.00 Strike: $89.76 | $0.00 |
DisclosureSEC source: 0001517737-24-000077 · edgardoc.xml · derivative · entry 9 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,899 Underlying: Common Stock · 4,212 shares Expires 2025-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted March 25, 2024. Read SEC document |
| June 25, 2024 Filed Jun 26, 2024 14:40 UTC | SYNOPSYS INC SNPS · Entity 210 | SaleCommon Stock | 4,212 | $600.05 | $2,527,413.97 |
DisclosureSEC source: 0001517737-24-000077 · edgardoc.xml · nonDerivative · entry 4 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,983 F2 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $600.00 to $600.28 The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| June 25, 2024 Filed Jun 26, 2024 14:40 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 4,212 | $89.76 | $378,069.12 |
DisclosureSEC source: 0001517737-24-000077 · edgardoc.xml · nonDerivative · entry 3 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2024 Filed Jun 26, 2024 14:40 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,535 | $0.00 Strike: $89.76 | $0.00 |
DisclosureSEC source: 0001517737-24-000077 · edgardoc.xml · derivative · entry 8 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,111 Underlying: Common Stock · 2,535 shares Expires 2025-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted March 25, 2024. Read SEC document |
| June 24, 2024 Filed Jun 26, 2024 14:40 UTC | SYNOPSYS INC SNPS · Entity 210 | SaleCommon Stock | 2,535 | $600.99 | $1,523,497.99 |
DisclosureSEC source: 0001517737-24-000077 · edgardoc.xml · nonDerivative · entry 2 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,983 F1 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $600.000 to $602.655. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| June 24, 2024 Filed Jun 26, 2024 14:40 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 2,535 | $89.76 | $227,541.60 |
DisclosureSEC source: 0001517737-24-000077 · edgardoc.xml · nonDerivative · entry 1 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 16:36 UTC | SYNOPSYS INC SNPS · Entity 210 | Disposition to issuerRestricted Stock Units · Derivative | 1,764 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001517737-24-000036 · edgardoc.xml · derivative · entry 6 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,290 Underlying: Common Stock · 1,764 shares Expires 2027-03-15 F2 · derivative.exercise_date: 25% of the units vest on the date shown followed by three equal annual installments, subject to continued service through each vesting date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 16:36 UTC | SYNOPSYS INC SNPS · Entity 210 | Tax withholdingCommon Stock | 610 | $550.03 | $335,518.30 |
DisclosureSEC source: 0001517737-24-000036 · edgardoc.xml · nonDerivative · entry 2 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,983 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the reporting person in connection with the vesting of an installment of the restricted stock unit award. The Compensation Committee approved the disposition of shares by the reporting person and the amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 16:36 UTC | SYNOPSYS INC SNPS · Entity 210 | Exercise / conversionCommon Stock | 1,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001517737-24-000036 · edgardoc.xml · nonDerivative · entry 1 DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 22:02 UTC | APPLIED MATERIALS INC /DE AMAT · Entity 2812 | GrantCommon Stock | 1,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009448 · form4.xml · nonDerivative · entry 1 DE GEUS AART · CIK 0001249802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,459 F1 · shares: Represents automatic annual grant of restricted stock units to a non-employee member of the Board of Directors pursuant to the Applied Materials, Inc. ("Applied") Employee Stock Incentive Plan. These restricted stock units will be converted on a one-for-one basis into shares of Applied common stock upon vesting, which vesting is scheduled to occur on March 1, 2025 (subject to continued service as a director through the vesting date). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.